Logo Image
News
Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Media
Expert ConnectionsTranslating TrialsCase-Based Peer PerspectivesPodcastsVideosShorts
Conferences
Conference CoverageConference Listing
Publications
More
CME/CE
Continuing Education
Resources
Case-Based Digest Rx Road MapEventsAdvanced Practice Corner
Partners

Subscribe

  • News
  • Media
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • Partners
  • Brain Cancer
  • Breast Cancer
    • Metastatic Breast Cancer
  • Gastrointestinal Cancer
    • Colorectal Cancer
    • Liver Cancer
    • Gastric Cancers
  • Genitourinary Cancer
    • Kidney Cancer
    • Bladder Cancer
    • Prostate Cancer
  • Gynecologic Cancers
    • Endometrial Cancer
    • Cervical Cancer
    • Ovarian Cancer
  • Head and Neck Cancers
  • Hematology
    • Leukemia
    • Graft-Vs-Host Disease
    • Myeloproliferative Neoplasms
    • Multiple Myeloma
    • Lymphoma
  • Lung Cancer
  • Pediatric Cancer
  • Sarcomas
  • Skin Cancer
    • Melanoma
Advertisement

Sam Rivera

Advertisement

Articles by Sam Rivera

Nurses and Practitioners Inspire Male Breast Cancer Survivor

BySam Rivera
March 14th 2019

Not many people knew about male breast cancer when Sam Rivera was diagnosed, but he took the information from his nurses to spread awareness about the disease.

Advertisement

Latest Updated Articles

  • Nurses and Practitioners Inspire Male Breast Cancer Survivor
    Nurses and Practitioners Inspire Male Breast Cancer Survivor

    March 14th 2019



Advertisement
Advertisement

Trending on Oncology Nursing News

1

FDA Approves Frontline Sevabertinib for HER2-Mutant Advanced NSCLC Patients

2

FDA Grants Final Approval to Cabozantinib Capsules Across Multiple Solid Tumor Indications

3

Personalizing Frontline ADC Selection in Metastatic Triple-Negative Breast Cancer

4

FDA Camizestrant Approval: Nurses Key to New Breast Cancer Paradigm

5

Frontline Sevabertinib Approved in HER2-Mutant NSCLC: Nursing Priorities

  • About Us
  • Editorial Board
  • Contact Us
  • CancerNetwork.com
  • CureToday.com
  • OncLive.com
  • TargetedOnc.com
  • Advertise
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us